Abstract:In this work, a multifunctional nanotheranostic agent FePDA/DOX@HA-CYS-TTDPP was constructed for photo/chemodynamic/chemo synergistic therapy guided by tumor-targeting fluorescence/photoacoustic dual-mode imaging. The diketopyrrolopyrrole (DPP) derivative (TTDPP) with near-infrared (NIR) absorption was coupled with tumor-targeting biomolecule hyaluronic acid (HA) via cystamine (CYS) to obtain the amphiphilic polymer HA-CYS-TTDPP. It was then self-assembled with Fe3+-coordinated 3+-coordinated polydopamine nanoparticles (FePDA) and anti-tumor drug doxorubicin (DOX) to form this nanomaterial. Its photothermal conversion efficiency reached 65.6% and it showed good photoacoustic performance, which can be attributed to the excellent photothermal conversion performance of TTDPP and PDA. TTDPP was a D-pi-A-pi-D type DPP derivative formed by the electron acceptor (A) DPP, the electron donor (D) triphenylamine, and the conjugated bridge thiophene, which exhibited excellent photothermal and photoacoustic performance, and a certain degree of photodynamic effect. PDA was formed by dopamine oxidation self-polymerization, which showed the advantages of good biocompatibility, high photothermal conversion efficiency, and easy functionalization; moreover, due to the d-d transition of exogenous Fe3+ 3+ in FePDA, the photothermal effect of PDA can be further enhanced. Furthermore, the weak acidity of tumor microenvironment (TME) facilitated the dissolution and release of DOX, and the overexpressed hyaluronidase (HAase) and glutathione (GSH) in tumor cells can also trigger the degradation of HA and the cleavage of disulfide bonds in CYS, respectively, leading to the release of DOX. Thus, the distance between DOX and PDA and TTDPP was increased, and the fluorescence of DOX was recovered, thereby achieving TME-responsive fluorescence activation and controlled drug release, and the tumor-targeting effect was further enhanced. Therefore, this nanotheranostic agent can realize triple response to the weak acidity, overexpressed GSH and HAase of TME. On the other hand, Fe3+ 3+ can react with GSH and H2O2 2 O 2 in tumor cells to induce Fenton reaction, generating cytotoxic center dot OH and resulting in chemodynamic therapeutic performance. Cell experiments confirmed that FePDA/DOX@HA-CYS-TTDPP can intelligently respond to TME and achieve targeted fluorescence imaging, and effectively inhibit the proliferation of HeLa tumor cells through photo/chemodynamic/chemo synergistic therapy. This system provides new ideas for achieving precise and efficient tumor theranostics.

Dual-Responsive Triple-Synergistic Fe-MOF for Tumor Theranostics

An intelligent ZIF-8-gated polydopamine nanoplatform for in vivo cooperatively enhanced combination phototherapy

Polydopamine-Based "Four-in-one" Versatile Nanoplatforms for Targeted Dual Chemo and Photothermal Synergistic Cancer Therapy

Multilayer nanodrug delivery system with spatiotemporal drug release improves tumor microenvironment for synergistic anticancer therapy

Theranostic Nanoplatform Based on Polydopamine-Coated Magnetic Mesoporous Silicon for Precise Cancer Triplex Nanotherapy and Multimodal Imaging

Dual-responsive nanoplatform for integrated cancer diagnosis and therapy: Unleashing the power of tumor microenvironment

Multistage-responsive nanovehicle to improve tumor penetration for dual-modality imaging-guided photodynamic-immunotherapy

MRI-guided dual-responsive anti-tumor nanostructures for synergistic chemo-photothermal therapy and chemodynamic therapy

NIR-/pH-Responsive Nanocarriers Based on Mesoporous Hollow Polydopamine for Codelivery of Hydrophilic/Hydrophobic Drugs and Photothermal Synergetic Therapy.

Mesoporous Polydopamine Nanoparticles with Co-Delivery Function for Overcoming Multidrug Resistance Via Synergistic Chemo-Photothermal Therapy.

Tumor-Microenvironment-Activatable Nanoreactor Based on a Polyprodrug for Multimodal-Imaging-Medicated Enhanced Cancer Chemo/Phototherapy

Metal–organic framework-based pH/NIR dual-responsive nanoparticles for combined photothermal/photodynamic therapy and chemotherapy of cancer

GSH/HAase/pH Triple-responsive Nanotheranostic Agent for Synergistic Therapy Guided by Tumor-targeting Fluorescence/Photoacoustic Dual-mode Imaging

Tumor therapy utilizing dual-responsive nanoparticles: A multifaceted approach integrating calcium-overload and PTT/CDT/chemotherapy

A tumor targeted near-infrared light-controlled nanocomposite to combat with multidrug resistance of cancer

Drug delivery system with dual imaging and dual response control drug release functions for chemo-photodynamic synergistic therapy

Multi-responsive nanotheranostics with enhanced tumor penetration and oxygen self-producing capacities for multimodal synergistic cancer therapy

Targeted intelligent mesoporous polydopamine nanosystems for multimodal synergistic tumor treatment

Supramolecular Modular Approach toward Conveniently Constructing and Multifunctioning a pH/Redox Dual-Responsive Drug Delivery Nanoplatform for Improved Cancer Chemotherapy

Ternary-Responsive Drug Delivery with Activatable Dual Mode Contrast-Enhanced in Vivo Imaging

Light/pH Dual Controlled Drug Release "nanocontainer" Alleviates Tumor Hypoxia for Synergistic Enhanced Chemotherapy, Photodynamic Therapy and Chemodynamic Therapy